共 50 条
Successful use of water-soluble contrast in patients with small bowel obstruction and virgin abdomen: A case report
被引:0
|作者:
de Figueiredo, Sergio Mazzola Poli
[1
]
Demola, Sara
[1
]
机构:
[1] Univ Texas Med Branch Hosp, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA
来源:
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS
|
2021年
/
79卷
关键词:
Small bowel obstruction;
Adhesions;
Virgin abdomen;
Water soluble contrast;
Nonoperative management;
Case report;
MANAGEMENT;
OPERATION;
SURGERY;
D O I:
暂无
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
INTRODUCTION AND IMPORTANCE: Nonoperative management of adhesive SBO is well established but remains a challenge in patients without prior abdominal surgery. We aim to report a case of successful nonoperative management with the use of enteral hypertonic water-soluble contrast administration in a patient with virgin abdomen. CASE PRESENTATION: A healthy 24-year old man with no previous surgery presented to the emergency room with one day of abdominal pain. A CT abdomen and pelvis was consistent with SBO without clear anatomic etiology. The patient refused surgical intervention, so we performed a trial of nonoperative management. On hospital day 2, a repeat CT A/P with enterally administered water-soluble contrast showed resolution of SBO. The patient has had no symptoms since hospital discharge on 6 months follow up. CLINICAL DISCUSSION: Small bowel obstruction is most commonly secondary to adhesions from prior surgeries. Even in patients with virgin abdomen, adhesions are the cause of SBO in 53%-73%. Recent studies in patients with virgin abdomen showed that 92.1% that underwent nonoperative management did not have a recurrence of SBO with mean follow up of 4.5 years. The use of water-soluble contrast in patients with virgin abdomen was reported to have 92-97% success rate. A meta-analysis showed a pooled prevalence of 7.7% of malignant etiology of SBO in these patients, more common with previous SBO admission or history of malignancy. CONCLUSION: Nonoperative management with the therapeutic use of hypertonic water-soluble contrast is a viable treatment option in select cases and avoids the morbidity of surgical exploration. (C) 2021 The Author( s). Published by Elsevier Ltd on behalf of BS Publishing Group Ltd.
引用
收藏
页码:94 / 96
页数:3
相关论文